These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27716276)

  • 1. Elevations in growth hormone and glucagon-like peptide-2 levels on admission are associated with increased mortality in trauma patients.
    Rowan MP; Beckman DJ; Rizzo JA; Isbell CL; White CE; Cohn SM; Chung KK
    Scand J Trauma Resusc Emerg Med; 2016 Oct; 24(1):119. PubMed ID: 27716276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of GH predict mortality and complement prognostic scores in critically ill medical patients.
    Schuetz P; Müller B; Nusbaumer C; Wieland M; Christ-Crain M
    Eur J Endocrinol; 2009 Feb; 160(2):157-63. PubMed ID: 19022915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of the growth hormone/insulin-like growth factor-I axis in critically ill children.
    Gardelis JG; Hatzis TD; Stamogiannou LN; Dona AA; Fotinou AD; Brestas PS; Constantopoulos AG
    J Pediatr Endocrinol Metab; 2005 Apr; 18(4):363-72. PubMed ID: 15844470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in total ghrelin within the somatotropic axis in severe burn patients: comparison of those with inhalation injury and those without inhalation injury.
    Lee BW; Park SH; Ihm SH; Kim JH; Kim DH; You KC; Kim SW; Yoo HJ
    Growth Horm IGF Res; 2008 Aug; 18(4):291-7. PubMed ID: 18178497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.
    de Groof F; Joosten KF; Janssen JA; de Kleijn ED; Hazelzet JA; Hop WC; Uitterlinden P; van Doorn J; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3118-24. PubMed ID: 12107211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intensive insulin therapy on the somatotropic axis of critically ill children.
    Gielen M; Mesotten D; Brugts M; Coopmans W; Van Herck E; Vanhorebeek I; Baxter R; Lamberts S; Janssen JA; Van den Berghe G
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2558-66. PubMed ID: 21632816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like Growth Factor I and its binding protein 3 in sepsis.
    Papastathi C; Mavrommatis A; Mentzelopoulos S; Konstandelou E; Alevizaki M; Zakynthinos S
    Growth Horm IGF Res; 2013 Aug; 23(4):98-104. PubMed ID: 23611528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database).
    Popovic V; Mattsson AF; Gaillard RC; Wilton P; Koltowska-Häggström M; Ranke MB
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4449-54. PubMed ID: 20610598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbance of the growth hormone-insulin-like growth factor-1 axis associated with poor performance status in patients with solid tumors.
    Okamoto I; Munakata M; Miyazaki M; Satoh T; Takahata T; Takamatsu Y; Muto O; Koike K; Ishitani K; Mukaiyama T; Sakata Y; Nakagawa K; Tamura K
    Jpn J Clin Oncol; 2010 Mar; 40(3):222-6. PubMed ID: 19942582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
    Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency.
    Juul A; Holm K; Kastrup KW; Pedersen SA; Michaelsen KF; Scheike T; Rasmussen S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2497-502. PubMed ID: 9253324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
    Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.